C-type natriuretic peptide: a new cardiac mediator

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Molecular Cardiology

Background:

• Natriuretic peptides are heart-released hormones responding to stretch and overload.
• Atrial and brain natriuretic peptides (ANP, BNP) are established cardiac hormones.
• C-type natriuretic peptide (CNP) research in cardiovascular regulation has gained traction recently.

Purpose of the Study:

• To review current literature on CNP's role in cardiovascular disease, focusing on heart failure (HF) and myocardial infarction (MI).
• To examine the progression of research understanding CNP's function in HF and MI.

Main Methods:

• Review of scientific literature on CNP and cardiovascular disease.
• Analysis of studies reporting increased CNP mRNA and plasma concentrations in human and animal models of HF and MI.
• Examination of research on CNP expression in cardiomyocytes and leukocytes.

Main Results:

• Evidence shows increased CNP expression and concentration in cardiovascular disease states.
• CNP's role extends beyond endothelium, with expression found in cardiomyocytes and leukocytes.
• CNP and its receptor NPR-B are implicated in regulating cardiac hypertrophy and remodeling.

Conclusions:

• CNP significantly contributes to cardiovascular function, particularly in HF and MI.
• The findings challenge the traditional view of CNP as solely an endothelial peptide.
• NPR-B emerges as a potential therapeutic target for cardiovascular disease treatment.